Markets

Allergan's Preferred Shares, Series A Yield Pushes Past 5.5%

A generic image of a pen on a chart
Credit: Shutterstock photo

In trading on Monday, shares of Allergan PLC's 5.500% Mandatory Convertible Preferred Shares, Series A (Symbol: AGN.PRA) were yielding above the 5.5% mark based on its quarterly dividend (annualized to $55.00), with shares changing hands as low as $997.10 on the day. This compares to an average yield of 9.11% in the "Drugs & Pharmaceuticals" preferred stock category, according to Preferred Stock Channel . As of last close, AGN.PRA was trading at a 1.00% premium to its liquidation preference amount, versus the average discount of 26.00% in the "Drugs & Pharmaceuticals" category. It should be noted that the preferred shares are convertible , with a conversion ratio of 2.8345 and 3.4722 .

The chart below shows the one year performance of AGN.PRA shares, versus AGN:

Performance Comparison Chart

Below is a dividend history chart for AGN.PRA, showing historical dividend payments on Allergan PLC's 5.500% Mandatory Convertible Preferred Shares, Series A:

AGN.PRA+Dividend+History+Chart

In Monday trading, Allergan PLC's 5.500% Mandatory Convertible Preferred Shares, Series A (Symbol: AGN.PRA) is currently off about 0.7% on the day, while the common shares (Symbol: AGN) are off about 0.1%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Investing

Latest Markets Videos

    BNK Invest

    BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.

    Learn More